Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01199900 · ClinicalTrials.gov registry record · Phase 1
Single Dose Study Of PF-04171327 And Prednisone On Carbohydrate Metabolism
A Phase 1 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 1
- Development phase
- 18
- Enrollment target
NCT01199900 is a Phase 1 study that has completed, run by Pfizer. The registered enrollment target is 18 participants.
The verdict
NCT01199900, a Phase 1 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 18 participants
- Enrollment target
Study Summary
This study will investigate the effect of a single dose of PF-04171327 or prednisone on calculated measures of glucose tolerance and insulin resistance by using a modified oral glucose tolerance test
Interventions
- DRUG Prednisone
- DRUG PF-04171327
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2010-08 |
| Est. Completion | 2010-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01199900
The ClinicalTrials.gov registry entry for NCT01199900 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Prednisone is the first listed.
NCT01199900 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01199900 about?
NCT01199900 is a clinical study titled "Single Dose Study Of PF-04171327 And Prednisone On Carbohydrate Metabolism". This study will investigate the effect of a single dose of PF-04171327 or prednisone on calculated measures of glucose tolerance and insulin resistance by using a modified oral glucose tolerance test
What is the current status of trial NCT01199900?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 18 participants. The study started on 2010-08. Estimated completion is 2010-09.
What interventions are being tested in trial NCT01199900?
The interventions under investigation include: Prednisone (DRUG), PF-04171327 (DRUG).
Who is sponsoring clinical trial NCT01199900?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.